Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
  Allergy & asthma
  Biotechnology
  Communicable diseases
  Drugs & drug processes
  Genetic engineering
  Genomics
  Health & ageing
  Health & poverty
  Health & special needs
  Health systems & management
  Major diseases
  Medical research
  Molecular biology
  Neuroscience
  Public health
  Rare & orphan diseases
  Other
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belgium
  Brazil
  Bulgaria
  Canada
  Chile
  China
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lithuania
  Luxembourg
  Malta
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Sweden
  Switzerland
  Taiwan
  Tunisia
  Turkey
  Ukraine
  United Kingdom
  United States


This page was published on 21/12/2007
Published: 21/12/2007

   Success Stories

Last Update: 21-12-2007  
Related category(ies):
Health & life sciences

 

Add to PDF "basket"

Number of Alzheimer's patients set to increase

Alzheimer's disease is most common amongst those over the age of 65. As the percentage of elderly people in Europe continually increases, this disease could prove problematic. There are even fears that, with such a massive strain, the health systems could approach a collapse.

Video in QuickTime format:  de  en  es  fr  it  pt  ru  (28 MB)

The typical symptoms of Alzheimer's disease include memory loss and orientation difficulties, leading to a loss of all cognitive functions. Asides from the direct effects on the patient, the disease causes much stress and trauma for the family of the patient. Sufferers of the disease can also develop behavioural problems: agitation, anxiousness or difficulties with sleeping. This normally needs to the carer/family requiring outside support.

Peter, 79, was a former design engineer with an active nature. Three years ago he started to show signs of memory loss and now he cannot cope on his own any more. His wife, Sylvia, who is also his carer, has seen how Peter has lost all recognition of his children, grandchildren, and the rest of his family.

It was at RICE, the Research Institute for the Care of the Elderly in Bath, England, where Peter was diagnosed with Alzheimer's disease. As part of a trial he is now testing new drugs against Alzheimer's disease. The current research taking place in Europe is aimed at understanding age related diseases and methods to lighten the burden on not just the patients, but also their carers.

At the Alzheimer Disease Research Centre at the Karolinska Institute in Stockholm, Sweden, Barbara Fahlen has herself tested for the disease. At the age of 62, she feels that she has become forgetful. A diagnosis involves a test of memory and spatial relationships. Although it is shown that she does not have the disease, she will return to the Institute in 18 months. An early diagnosis can be useful in identifying possible causes of cognitive impairment.

Another useful diagnostic tool is MRI (Magnetic Resonance Imaging), a type of neuro-imaging, which can analyse the brain structure. With the patient in a strong magnetic field, 3D images can be made of the tissue, in this case brain tissue. MRI scans can show the typical degeneration and shrinkage of a brain from a sufferer of advanced Alzheimer's disease.

It is also possible to see the disease in brain tissue samples. It appears as dark flecks known as plaques and tangles. A plaque is a build-up of the protein beta amyloid that blocks their signals sent by neurons. Tangles are the disjointed nerve endings, typical of the disease. With the identification of beta amyloid and the arrival of the first generation of drug treatment, there is now some hope in combating the disease.

It is evident that certain lifestyle factors can contribute to the likelihood of Alzheimer's disease. An active lifestyle, mental training and social involvement can decrease the risk, furthermore factors like avoiding high blood pressure, cholesterol and obesity. Miia Kivipelto, associate professor at the Karolinska Institute, gives the good advice: “Everything that is good for the heart is also good for the brain.”

Alzheimer's disease was earlier believed to be the natural course of events as one grows old, and certainly not common enough to be of any concern. Today it is estimated that there are about 26 million sufferers world-wide. With an increasing aged population, that number is expected to be four times that of today by 2050. It is estimated that by 2025 the percentage of over-65s will raise from 15.4% of the EU population to 22.4%, which will be in correlation with a rise of Alzheimer's disease patients. Now the race is on to find a treatment or cure before the burden on the health systems become too much.

Convert article(s) to PDF

No article selected


loading


Search articles
To restrict search results to articles in the Information Centre, i.e. this site, use the search box at the top of the page to the right of the menu and then select "Information Centre" in the "Filter by" menu on the results page.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Futuris, the European research programme - on Euronews. The video on this page was prepared in collaboration with Euronews for the Futuris programme.

Contacts
Unit A1 - External & internal communication,
Directorate-General for Research & Innovation,
European Commission
Tel : +32 2 298 45 40
  Top   Research Information Center